Video PlayerClose TOKYO, Nov. 24 (Xinhua) — Tokyo stocks opened sharply higher on Tuesday, as investor sentiment boosted after a potential COVID-19 vaccine developed by the University of Oxford and British drugmaker AstraZeneca Plc showed up to 90 percent efficacy in late-stage trials. As of 9:15 a.m., the 225-issue Nikkei Stock Average increased 476.84 points, or 1.87 percent, from Friday to 26,004.21. The broader Topix index of all First Section issues on the Tokyo Stock Exchange rose 32.02 points, or 1.85 percent, at 1,759.41. Japanese markets were closed Monday due to a national holiday. Metal product, iron and steel and securities house issues comprised those that gained the most in the opening minutes after the morning bell. Enditem
- Stock market opens sharply higher on U.S., China trade truce
- Tokyo stocks open higher after Tuesday's sharp plunge
- Markets Right Now: Stocks open sharply lower on Wall Street
- Stocks open sharply lower on Wall Street
- Stocks drop sharply as technology companies tumble
- Dow slides 700 points as U.S. stocks veer sharply lower
- Dow slides 700 points as stocks veer sharply lower
- Tech giants slump, stocks fall sharply
- Dow slides 700 points as US stocks veer sharply lower
- U.S. stocks head sharply lower a day after Dow's record gain
Tokyo stocks open sharply higher on COVID-19 vaccine progress have 200 words, post on www.xinhuanet.com at November 24, 2020. This is cached page on Asean Breaking News. If you want remove this page, please contact us.
